News|Webcasts|March 3, 2025
FSP Outsourcing Trends and Opportunities
Webinar Date/Time: Tuesday, April 1, 2025 at 11:00 AM EST
Advertisement
Join experts from PPD FSP solutions as they discuss the latest FSP trends and opportunities in clinical development, innovative FSP strategies and models, and keys to successfully leveraging an FSP model to drive on-time and on-budget delivery.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/fsp-outsourcing-trends
Event overview
Join experts from PPD FSP solutions—part of the PPD clinical research business of Thermo Fisher Scientific—as they discuss the latest utilization and growth projections of FSP partnerships in the clinical research and development landscape, innovative FSP strategies to address drug development challenges and opportunities, and keys to successfully leveraging an FSP model to drive on-time and on-budget delivery.
Join experts from PPD FSP solutions—part of the PPD clinical research business of Thermo Fisher Scientific—as they discuss the latest utilization and growth projections of FSP partnerships in the clinical research and development landscape, innovative FSP strategies to address drug development challenges and opportunities, and keys to successfully leveraging an FSP model to drive on-time and on-budget delivery.
Key Learning Objectives
- Understand the latest utilization and growth projection of FSP partnerships in the clinical research and development landscape
- Learn about innovative FSP strategies and models to address drug development challenges and opportunities
- Identify the keys to successfully leveraging an FSP model to drive on-time, on-budget delivery
Who Should Attend
Biopharma and biotech company employees involved in:
Biopharma and biotech company employees involved in:
- Clinical development
- Biostatistics and programming
- Clinical data management
- Clinical development
- Clinical operations
- Clinical monitoring
- Clinical research
- Clinical supplies
- Medical affairs
- Medical writing
- Pharmacovigilance
- Project delivery
- Quality assurance/control
- Regulatory affairs
- Sites & patients
- Study start up
- Therapeutic area leads
- Business services
- Alliance management/partnering
- Finance
- Procurement
- Purchasing
- Vendor management
Speakers:
Lori Boyce
Vice President
PPD FSP Solution
Vice President
PPD FSP Solution
Lori Boyce has more than 25 years of experience in the field of clinical research and more than 18 years of experience in clinical operations. She has a broad range of experience working with clients to identify innovative solutions to operational and strategic priorities.
Mike Lydon
Director
PPD FSP Solutions
Mike Lydon
Director
PPD FSP Solutions
Mike Lydon has more than 16 years of experience within the clinical research industry and has held various leadership roles within the FSP sales and talent resourcing space for top clinical research organizations. His consultative approach to partnerships helps his customers practice innovation, accelerate quality, and reduce burdens.
Register Free:https://www.appliedclinicaltrialsonline.com/act_w/fsp-outsourcing-trends
Register Free:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- How Recent Policy Changes Could Impact Clinical Research
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- What Resilient Trial Design Means for Clinical Teams
September 2nd 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
3
Latest NIMBLE Study Results Highlight Progress in gMG Research
4
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
5